Cevidra brings in biotech expert profile to drive the advent of next-generation medicines to the French market
We’re pleased to announce Loïc FIEVET, PharmD, PhD, will serve as a new Deputy Qualified Person of Cevidra company through its next chapter, as it aims to bring new #EarlyAccess medicines to French patients.
After a first milestone in clinical trial bioproduction sites as QC manager, notably at EFS in collaboration with the CHU de Toulouse, he then advised multiple biotechnology companies as scientific expert of advanced therapy medicinal products (ATMP).
His arrival and network will open new perspectives in our #biotechnology and #ATMP portfolio.
Welcome on Board!
